Feedback PLC Official Launch of Bleepa Box
23 Setembro 2021 - 03:00AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
23 September 2021
Feedback plc
RNS REACH
Feedback announces official launch of Bleepa Box to enable
connected imaging in remote locations
-- Enables capture and rapid transfer of medical images from
remote locations to the Bleepa platform over mobile networks
-- Images acquired in remote settings can be instantly reviewed
by specialists in other locations, connected via the Bleepa
platform for instant case discussion, enabling point of care
patient management
-- Multiple commercial opportunities including veterinary,
international markets and the military
London, 23 September 2021 : Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist clinical communication company,
announces that following the success of the store and forward
concept delivered in partnership with the equine division of CVS
Group plc it is officially launching Bleepa Box, a specialist tool
to enable image transfer from remote settings to the Bleepa
platform.
Bleepa Box is a small tablet device that connects to imaging
machines in order to securely push images to Bleepa over a mobile
network from remote locations. Crucially Bleepa does not need WiFi
access. Images are downloaded from the imaging machine onto the
Bleepa Box then automatically pushed to Bleepa. The clinician who
acquired the images can then review the images directly on the
Bleepa Box and can make onward referrals or start a conversation
with a specialist for input on the case whilst still in the remote
location. This enables rapid decision making and treatment of the
patient within that first visit, at the point of care, for cases
that previously would have required transfer to treatment centres
for imaging and management. This enables new capabilities around
remote investigation and patient management, allowing patient
imaging to be carried out and discussed in settings that were
previously unreachable for traditional care models.
In addition to the veterinary imaging market which is growing at
a compound annual growth rate of 6.7% and is expected to be worth
an estimated GBP2.24bn in the UK(1) by 2025, Bleepa Box's remote
image capabilities are relevant to a number of other significant
commercial opportunities including the delivery of rural imaging
for TB screening services in India, as announced in our MOU with
Qure.ai on 14 September 2021 and routes to support the military
infield market.
Dr Tom Oakley, CEO of Feedback, said: "This technology was a
solution created, designed and launched to support the work we are
doing in the veterinary market with CVS and we are now taking the
steps to formally build a brand around this capability. Imaging of
horses is typically done in remote stables without WiFi, but there
is often the need for timely advice and guidance by specialists
whilst the vet is with the animal. We developed the store and
forward technology that enables them to analyse and treat animals
on site, which reduces the vet's workload, travel time and is
certainly better for the animal. However, clearly there are other
markets that have this requirement and formally branding the
solution as Bleepa Box enables us to build a market around this
capability across a range of industries. We anticipate that the
product can be sold in combination with Bleepa or potentially as a
standalone offering to facilitate image sharing to other
third-party systems such as PACS."
Further information on Bleepa Box and the company's product
focus can be found on the Company's website
https://fbkmed.com/feedback-plc/reports-and-presentations/
1. Veterinary Imaging Market - Global Forecast to 2025 | MarketsandMarkets
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas Johnson 07980 541 893 or 07748 325 236
or 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a pioneer of regulated clinical
communication products. Its core product, Bleepa, is a
revolutionary medical imaging communications app, providing an
easy-to-use, high quality tool to enable remote and secure
communications between front-line clinicians and teams.
Importantly, it is the only CE marked medical imaging
communications platform on the NHSx clinical communications tools
framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care providers. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of clinical
review.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUUOVRAUUKUAR
(END) Dow Jones Newswires
September 23, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Feedback (LSE:FDBK)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024